Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinnamon
NCT07432178Phase 3Recruiting
- Sponsor
- Fudan University
- Start
- Apr 2026
- Primary completion
- Mar 2031
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dalpiciclib in breast cancer, sponsored by Fudan University. Started Apr 2026; status: recruiting.
02
Drugs
dalpiciclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07432178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07432178.